BioCentury
ARTICLE | Company News

Advancell, Helsinn deal

July 15, 2013 7:00 AM UTC

Advancell granted Helsinn exclusive, worldwide rights to develop and commercialize ATH008. The undisclosed topical cream is in development to treat palmoplantar erythrodysesthesia syndrome (PPES) and...